Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GBR 13069 is a dopamine uptake inhibitor.1 It selectively inhibits dopamine uptake over norepinephrine uptake in rat occipital cortex slices (IC50s = 40 and 800 nM, respectively). GBR 13069 (2.5, 5, and 10 mg/kg) induces ipsilateral rotation and increases locomotion in rats. It also prevents 2’-CH3-MPTP-induced decreases in neostriatal levels of the endogenous catecholamine dopamine (Item No. 36532) and its metabolites DOPAC (3,4-dihydroxyphenylacetic acid; Item No. 24912) and homovanillic acid (HVA; Item No. 27307) in mice when administered at a dose of 5 mg/kg.2
WARNING This product is not for human or veterinary use.
1. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake. Eur. J. Pharmacol. 103(3-4), 241-248 (1984).
2. Characteristics of 1-